Vertex (VRTX) files Form 144 for 1,541 shares

Vertex Pharmaceuticals reported a proposed sale notice on Form 144 listing 1,541 shares of Common Stock associated with Fidelity Brokerage Services LLC.

Rhea-AI Filing Summary

Vertex Pharmaceuticals reported a proposed sale notice on Form 144 listing 1,541 shares of Common Stock associated with Fidelity Brokerage Services LLC. The filing also lists restricted stock vesting events of 612 shares on 02/17/2026 and 929 shares on 02/24/2026.

Insights

Insider Transactions Compliance Analyst

Form 144 lists a proposed disposition of common stock tied to recent restricted stock vesting.

Form 144 is a notice of proposed sale under Section 16(b) mechanics; the entry shows brokerage placement through Fidelity Brokerage Services LLC and two restricted stock vesting events dated 02/17/2026 and 02/24/2026

Timing and exact sale mechanics are not detailed here; subsequent Form 4 or broker reports would show execution and proceeds. Follow-up filings will confirm whether the proposed sale was completed.

Key Figures

Proposed shares: 1,541 shares Vesting event 1: 612 shares Vesting event 2: 929 shares +1 more

4 metrics

Proposed shares 1,541 shares listed on Form 144

Vesting event 1 612 shares Restricted stock vesting on <date>02/17/2026</date>

Vesting event 2 929 shares Restricted stock vesting on <date>02/24/2026</date>

Broker Fidelity Brokerage Services LLC listed as broker on Form 144

Key Terms

Form 144, Restricted Stock Vesting, Fidelity Brokerage Services LLC

3 terms

Form 144 regulatory

"listed as the filing type for proposed sale notices"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"entries showing 612 and 929 shares vesting on specific dates"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Fidelity Brokerage Services LLC other

"named as broker at 900 Salem Street Smithfield RI"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the VRTX Form 144 report show?

The filing reports a proposed sale of 1,541 shares of common stock and lists restricted stock vesting of 612 shares and 929 shares on 02/17/2026 and 02/24/2026, respectively.

Does Form 144 mean the shares were sold for VRTX?

No. Form 144 is a notice of intent to sell; it does not confirm execution. Completion and sale proceeds would appear in later transaction reports or broker statements.

Who is the broker named in the VRTX Form 144?

The filing lists Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield RI as the broker associated with the proposed transaction.

Are the 612 and 929 shares part of the registered sale?

The filing lists vesting events of 612 and 929 shares on specified dates; the document links these to compensation vesting but does not explicitly state which shares were sold under the Form 144 notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 02:16 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002062139
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERTEX PHARMACEUTICALS INC / MA
SEC File Number	000-19319
Address of Issuer	50 NORTHERN AVENUE BOSTON MASSACHUSETTS 02210
Phone	6173416393
Name of Person for Whose Account the Securities are To Be Sold	McKechnie Duncan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1541	799779.00	253805417	07/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2026	Restricted Stock Vesting	Issuer			612	02/17/2026	Compensation
Common	02/24/2026	Restricted Stock Vesting	Issuer			929	02/24/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	07/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/25/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Adam Gehring, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Duncan J. Mckechnie
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)